|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
National Cancer Center, . Latest Cancer
Statistics. https://ganjoho.jp/reg_stat/statistics/stat/summary.htmlFebruary
24–2023(In Japanese).
|
|
3
|
Koike T, Yamato Y, Asamura H, Tsuchiya R,
Sohara Y, Eguchi K, Mori M, Nakanishi Y, Goya T, Koshiishi Y, et
al: Improvements in surgical results for lung cancer from 1989 to
1999 in Japan. J Thorac Oncol. 4:1364–1369. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wood DE, Kazerooni EA, Baum SL, Eapen GA,
Ettinger DS, Hou L, Jackman DM, Klippenstein D, Kumar R, Lackner
RP, et al: Lung cancer screening, version 3.2018, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
16:412–441. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gavelli G and Giampalma E: Sensitivity and
specificity of chest X-ray screening for lung cancer: Review
article. Cancer. 89 (11 Suppl):S2453–S2456. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ando W, Kikuchi K, Uematsu T, Yokomori H,
Takaki T, Sogabe M, Kohgo Y, Otori K, Ishikawa S and Okazaki I:
Novel breast cancer screening: Combined expression of miR-21 and
MMP-1 in urinary exosomes detects 95% of breast cancer without
metastasis. Sci Rep. 9:135952019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Anastasiadou E and Slack FJ: Cancer.
Malicious exosomes. Science. 346:1459–1460. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kalluri R: The biology and function of
exosomes in cancer. J Clin Invest. 126:1208–1215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang L and Yu D: Exosomes in cancer
development, metastasis, and immunity. Biochim Biophys Acta Rev
Cancer. 1871:455–468. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okazaki I and Nabeshima K: Introduction:
MMPs, ADAMs/ADAMTSs research products to achieve big dream.
Anticancer Agents Med Chem. 12:688–706. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rutter JL, Mitchell TI, Butticè G, Meyers
J, Gusella JF, Ozelius LJ and Brinckerhoff CE: A single nucleotide
polymorphism in the matrix metalloproteinase-1 promoter creates an
Ets binding site and augments transcription. Cancer Res.
58:5321–5325. 1998.PubMed/NCBI
|
|
13
|
Zhu Y, Spitz MR, Lei L, Mills GB and Wu X:
A single nucleotide polymorphism in the matrix metalloproteinase-1
promoter enhances lung cancer susceptibility. Cancer Res.
61:7825–7829. 2001.PubMed/NCBI
|
|
14
|
Su L, Zhou W, Park S, Wain JC, Lynch TJ,
Liu G and Christiani DC: Matrix metalloproteinase-1 promoter
polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers
Prev. 14:567–570. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sauter W, Rosenberger A, Beckmann L, Kropp
S, Mittelstrass K, Timofeeva M, Wölke G, Steinwachs A, Scheiner D,
Meese E, et al: Matrix metalloproteinase 1 (MMP1) is associated
with early-onset lung cancer. Cancer Epidemiol Biomarkers Prev.
17:1127–1135. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen J, Liu Z, Todd NW, Zhang H, Liao J,
Yu L, Guarnera MA, Li R, Cai L, Zhan M and Jiang F: Diagnosis of
lung cancer in individuals with solitary pulmonary nodules by
plasma microRNA biomarkers. BMC Cancer. 11:3742011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu LF, Wu ZP, Chen Y, Zhu QS, Hamidi S and
Navab R: MicroRNA-21 (miR-21) regulates cellular proliferation,
invasion, migration, and apoptosis by targeting PTEN, RECK and
Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One.
9:e1036982014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
ElKhouly AM, Youness RA and Gad MZ:
MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic
mediators in oncological and non-oncological conditions. Noncoding
RNA Res. 5:11–21. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian F, Wang J, Ouyang T, Lu N, Lu J, Shen
Y, Bai Y, Xie X and Ge Q: MiR-486-5p serves as a good biomarker in
nonsmall cell lung cancer and suppresses cell growth with the
involvement of a target PIK3R1. Front Genet. 10:6882019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A, Bolejack V, et al: The IASLC lung cancer staging
project: Proposals for revision of the TNM stage groupings in the
forthcoming (eighth) edition of the TNM classification for lung
cancer. J Thorac Oncol. 11:39–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH image to ImageJ: 25 Years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schutz A, Schneidenbach D, Aust G,
Tannapfel A, Steinert M and Wittekind C: Differential expression
and activity status of MMP-1, MMP-2 and MMP-9 in tumor and stromal
cells of squamous cell carcinomas of the lung. Tumour Biol.
23:179–184. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
An HJ, Lee YJ, Hong SA, Kim JO, Lee KY,
Kim YK, Park JK and Kang JH: The prognostic role of tissue and
serum MMP-1 and TIMP-1 expression in patients with non-small cell
lung cancer. Pathol Res Pract. 212:357–364. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li M, Xiao T, Zhang Y, Feng L, Lin D, Liu
Y, Mao Y, Guo S, Han N, Di X, et al: Prognostic significance of
matrix metalloproteinase-1 levels in peripheral plasma and tumour
tissues of lung cancer patients. Lung Cancer. 69:341–347. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schütz A, Röser K, Klitzsch J, Lieder F,
Aberger F, Gruber W, Mueller KM, Pupyshev A, Moriggl R and
Friedrich K: Lung adenocarcinomas and lung cancer cell lines show
association of MMP-1 expression with STAT3 activation. Transl
Oncol. 8:97–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park S, Jung HH, Park YH, Ahn JS and Im
YH: ERK/MAPK pathways play critical roles in EGFR ligands-induced
MMP1 expression. Biochem Biophys Res Commun. 407:680–686. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tanaka M, Yoshimoto T and Nakamura T: A
double-edged sword: The world according to Capicua in cancer.
Cancer Sci. 108:2319–2325. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiménez G, Shvartsman SY and Paroush Z:
The Capicua repressor-a general sensor of RTK signaling in
development and disease. J Cell Sci. 125:1383–1391. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee Y, Fryer JD, Kang H, Crespo-Barreto J,
Bowman AB, Gao Y, Kahle JJ, Hong JS, Kheradmand F, Orr HT, et al:
ATXN1 protein family and CIC regulate extracellular matrix
remodeling and lung alveolarization. Dev Cell. 21:746–757. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Okimoto RA, Breitenbuecher F, Olivas VR,
Wu W, Gini B, Hofree M, Asthana S, Hrustanovic G, Flanagan J,
Tulpule A, et al: Inactivation of Capicua drives cancer metastasis.
Nat Genet. 49:87–96. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim E, Kim D, Lee JS, Yoe J, Park J, Kim
CJ, Jeong D, Kim S and Lee Y: Capicua suppresses hepatocellular
carcinoma progression by controlling the ETV4-MMP1 axis.
Hepatology. 67:2287–2301. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiménez G, Guichet A, Ephrussi A and
Casanova J: Relief of gene repression by torso RTK signaling: Role
of capicua in Drosophila terminal and dorsoventral
patterning. Genes Dev. 14:224–231. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Saito R, Miki Y, Ishida N, Inoue C,
Kobayashi M, Hata S, Yamada-Okabe H, Okada Y and Sasano H: The
significance of MMP-1 in EGFR-TKI-resistant lung adenocarcinoma:
Potential for therapeutic targeting. Int J Mol Sci. 19:6092018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Niland S, Riscanevo AX and Eble JA: Matrix
metalloproteinases shape the tumor microenvironment in cancer
progression. Int J Mol Sci. 23:1462021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Murray GI, Duncan ME, O'Neil P, Melvin WT
and Fothergill JE: Matrix metalloproteinase-1 is associated with
poor prognosis in colorectal cancer. Nat Med. 2:461–462. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cazzoli R, Buttitta F, Di Nicola M,
Malatesta S, Marchetti A, Rom WN and Pass HI: microRNAs derived
from circulating exosomes as noninvasive biomarkers for screening
and diagnosing lung cancer. J Thorac Oncol. 8:1156–1162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou X, Wen W, Shan X, Zhu W, Xu J, Guo R,
Cheng W, Wang F, Qi LW, Chen Y, et al: A six-microRNA panel in
plasma was identified as a potential biomarker for lung
adenocarcinoma diagnosis. Oncotarget. 8:6513–6525. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang L, Shan X, Wang J, Zhu J, Huang Z,
Zhang H, Zhou X, Cheng W, Shu Y, Zhu W and Liu P: A three-microRNA
signature for lung squamous cell carcinoma diagnosis in Chinese
male patients. Oncotarget. 8:86897–86907. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dejima H, Iinuma H, Kanaoka R, Matsutani N
and Kawamura M: Exosomal microRNA in plasma as a non-invasive
biomarker for the recurrence of non-small cell lung cancer. Oncol
Lett. 13:1256–1263. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shan X, Zhang H, Zhang L, Zhou X, Wang T,
Zhang J, Shu Y, Zhu W, Wen W and Liu P: Identification of four
plasma microRNAs as potential biomarkers in the diagnosis of male
lung squamous cell carcinoma patients in China. Cancer Med.
7:2370–2381. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Feng M, Zhao J, Wang L and Liu J:
Upregulated expression of serum exosomal micrornas as diagnostic
biomarkers of lung adenocarcinoma. Ann Clin Lab Sci. 48:712–718.
2018.PubMed/NCBI
|
|
44
|
Zhang Y, Zhang Y, Yin Y and Li S:
Detection of circulating exosomal miR-17-5p serves as a novel
non-invasive diagnostic marker for non-small cell lung cancer
patients. Pathol Res Pract. 215:1524662019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang R, Bhat-Nakshatri P, Zhong X, Zimmers
T and Nakshatri H: Hormonally regulated myogenic miR-486 influences
sex-specific differences in cancer-induced skeletal muscle defects.
Endocrinology. 162:bqab1422021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Thakur L and Thakur S: The interplay of
sex steroid hormones and microRNAs in endometrial cancer: Current
understanding and future directions. Front Endocrinol (Lausanne).
14:11669482023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pao W, Miller V, Zakowski M, Doherty J,
Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, et al:
EGF receptor gene mutations are common in lung cancers from ‘never
smokers’ and are associated with sensitivity of tumors to gefitinib
and erlotinib. Proc Natl Acad Sci USA. 101:13306–13311. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Matsuzaki K, Fujita K, Jingushi K,
Kawashima A, Ujike T, Nagahara A, Ueda Y, Tanigawa G, Yoshioka I,
Ueda K, et al: MiR-21-5p in urinary extracellular vesicles is a
novel biomarker of urothelial carcinoma. Oncotarget. 8:24668–24678.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yazarlou F, Mowla SJ, Oskooei VK,
Motevaseli E, Tooli LF, Afsharpad M, Nekoohesh L, Sanikhani NS,
Ghafouri-Fard S and Modarressi MH: Urine exosome gene expression of
cancer-testis antigens for prediction of bladder carcinoma. Cancer
Manag Res. 10:5373–5381. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Occhipinti G, Giulietti M, Principato G
and Piva F: The choice of endogenous controls in exosomal microRNA
assessments from biofluids. Tumour Biol. 37:11657–11665. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xu D, Di K, Fan B, Wu J, Gu X, Sun Y, Khan
A, Li P and Li Z: MicroRNAs in extracellular vesicles: Sorting
mechanisms, diagnostic value, isolation, and detection technology.
Front Bioeng Biotechnol. 10:9489592022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Benz F, Roderburg C, Vargas Cardenas D,
Vucur M, Gautheron J, Koch A, Zimmermann H, Janssen J,
Nieuwenhuijsen L, Luedde M, et al: U6 is unsuitable for
normalization of serum miRNA levels in patients with sepsis or
liver fibrosis. Exp Mol Med. 45:e422013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Okazaki I, Ishikawa S, Ando W and Sohara
Y: Lung adenocarcinoma in never smokers: Problems of primary
prevention from aspects of susceptible genes and carcinogens.
Anticancer Res. 36:6207–6224. 2016. View Article : Google Scholar : PubMed/NCBI
|
